Compare Elder Pharma with Fulford India - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ELDER PHARMA vs FULFORD INDIA - Comparison Results

FULFORD INDIA 
   Change

Fulford (India) Limited is an Indian affiliate of Schering-Plough Corporation, USA. The company has presence in oncology, virology and cardiovascular segments. In FY06 the topline of the company grew by 15.5% to Rs. 1519 m from Rs. 1279 m in FY05. PA... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ELDER PHARMA FULFORD INDIA ELDER PHARMA/
FULFORD INDIA
 
P/E (TTM) x -0.2 398.8 - View Chart
P/BV x 0.1 6.2 1.6% View Chart
Dividend Yield % 0.0 0.1 -  

Financials

 ELDER PHARMA   FULFORD INDIA
EQUITY SHARE DATA
    ELDER PHARMA
Jun-14
FULFORD INDIA
Mar-14
ELDER PHARMA/
FULFORD INDIA
5-Yr Chart
Click to enlarge
High Rs380942 40.3%   
Low Rs188450 41.8%   
Sales per share (Unadj.) Rs491.2691.4 71.0%  
Earnings per share (Unadj.) Rs-3.211.5 -27.8%  
Cash flow per share (Unadj.) Rs14.415.4 93.8%  
Dividends per share (Unadj.) Rs02.00 0.0%  
Dividend yield (eoy) %00.3 0.0%  
Book value per share (Unadj.) Rs376.5380.0 99.1%  
Shares outstanding (eoy) m20.543.90 526.7%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.61.0 57.4%   
Avg P/E ratio x-89.360.7 -147.0%  
P/CF ratio (eoy) x19.745.3 43.5%  
Price / Book Value ratio x0.81.8 41.2%  
Dividend payout %017.4 0.0%   
Avg Mkt Cap Rs m5,8332,714 214.9%   
No. of employees `000NA0.4 0.0%   
Total wages/salary Rs m2,179505 431.5%   
Avg. sales/employee Rs ThNM6,073.0-  
Avg. wages/employee Rs ThNM1,137.4-  
Avg. net profit/employee Rs ThNM100.7-  
INCOME DATA
Net Sales Rs m10,0892,696 374.2%  
Other income Rs m257125 204.6%   
Total revenues Rs m10,3462,822 366.6%   
Gross profit Rs m-792-46 1,706.7%  
Depreciation Rs m36115 2,377.0%   
Interest Rs m2,75610 29,013.7%   
Profit before tax Rs m-3,65354 -6,727.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m3,7130-   
Tax Rs m12510 1,303.6%   
Profit after tax Rs m-6545 -146.2%  
Gross profit margin %-7.8-1.7 456.1%  
Effective tax rate %-3.417.7 -19.4%   
Net profit margin %-0.61.7 -39.1%  
BALANCE SHEET DATA
Current assets Rs m9,2401,738 531.6%   
Current liabilities Rs m9,998545 1,835.4%   
Net working cap to sales %-7.544.3 -17.0%  
Current ratio x0.93.2 29.0%  
Inventory Days Days4648 95.5%  
Debtors Days Days604 1,392.4%  
Net fixed assets Rs m10,12412 85,073.1%   
Share capital Rs m20639 527.4%   
"Free" reserves Rs m5,5821,443 386.9%   
Net worth Rs m7,7341,482 521.8%   
Long term debt Rs m4,8890-   
Total assets Rs m22,8822,077 1,101.8%  
Interest coverage x-0.36.7 -4.8%   
Debt to equity ratio x0.60-  
Sales to assets ratio x0.41.3 34.0%   
Return on assets %11.82.6 450.6%  
Return on equity %-0.83.0 -28.0%  
Return on capital %22.34.3 518.2%  
Exports to sales %3.00-   
Imports to sales %0.424.5 1.7%   
Exports (fob) Rs m307NA-   
Imports (cif) Rs m43659 6.5%   
Fx inflow Rs m30717 1,782.6%   
Fx outflow Rs m125673 18.6%   
Net fx Rs m181-656 -27.6%   
CASH FLOW
From Operations Rs m11,75490 13,060.1%  
From Investments Rs m-561105 -535.9%  
From Financial Activity Rs m-6,762-14 47,956.0%  
Net Cashflow Rs m4,432181 2,455.2%  

Share Holding

Indian Promoters % 39.6 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 7.5 3.8 197.4%  
FIIs % 16.8 0.1 16,800.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 36.1 21.2 170.3%  
Shareholders   16,479 4,783 344.5%  
Pledged promoter(s) holding % 77.6 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ELDER PHARMA With:   WYETH LTD  IPCA LABS  JUBILANT LIFE SCIENCES  SUN PHARMA  PIRAMAL ENTERPRISES  

Compare ELDER PHARMA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades in Green; Bajaj Finance and ICICI Bank Top Gainers(12:30 pm)

Stock markets in India are presently trading on a positive note. The BSE Sensex is trading up by 90 points and the NSE Nifty is trading up by 35 points.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound(Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Finally, Is the Share Price of Yes Bank Ready for a Rebound?(The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

Rebound Riches Could be Yours With These Stocks(Profit Hunter)

Oct 4, 2019

The secret to multibagger is not big businesses, but great managements... Here's how to find them to make the most of once in a decade rebound opportunity.

The One Stock I Like in this Market(The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

5 Smart Money Stocks to Profit from the Market Rebound(The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

ELDER PHARMA SHARE PRICE


Sep 12, 2016 (Close)

TRACK ELDER PHARMA

  • Track your investment in ELDER PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ELDER PHARMA 5-YR ANALYSIS

COMPARE ELDER PHARMA WITH

MARKET STATS